Table 1.
Compound | Virus yield assay in MDCK cells |
vRNP reconstitution assay in HEK293T cells |
||||
---|---|---|---|---|---|---|
Antiviral activityb |
Cytotoxicity (CC50c) at: |
Activity (EC50d) | Cytotoxicity (CC50) at 24 h |
|||
EC90 | EC99 | 24 h | 72 h | |||
L-742,001 | 4.3 ± 0.8 | 6.6 ± 1.3 | 171 ± 23 | 62 ± 26 | 3.8 ± 1.5 | 255 ± 46 |
Ribavirin | 7.8 ± 0.8 | 11 ± 1 | >400 | >400 | 9.7 ± 1.8 | >400 |
Data shown are the means ± standard errors of the means (SEM) from at least 3 independent tests.
Compound concentration causing a 1-log10 (EC90) or 2-log10 (EC99) reduction in virus yield at 24 h p.i., as determined by real-time RT-PCR.
CC50, 50% cytotoxic concentration, as determined by MTS cell viability assay.
EC50, 50% effective concentration, i.e., compound concentration producing 50% reduction in vRNP-driven firefly reporter signal, estimated at 24 h after transfection.